When is an HIV infection prevented and when is it merely delayed?

Evaluation Review

Volumn 24, Issue 3, 2000, Pages 251-270

  Pinkerton, Steven D ^a   Chesson, Harrell W ^a   Holtgrave, David R ^a   Kassler, William ^a   Layde, Peter M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; REVIEW; RISK; STATISTICS; THEORETICAL MODEL;

COMMUNICABLE DISEASE CONTROL; COST-BENEFIT ANALYSIS; HIV INFECTIONS; HUMANS; MODELS, THEORETICAL; RISK;

EID: 0034200550     PISSN: 0193841X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0193841x0002400301     Document Type: Article

References (40)

1. Anderson, R. M. 1991. Mathematical models of the potential demographic impact of AIDS in Africa. AIDS 5 (suppl. 1): S37-S44.
2. Centers for Disease Control and Prevention. 1998. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission: Thailand, 1996-1998. Morbidity and Mortality Weekly Report 47:151-54.
3. Cummings, S. R., D. M. Black, and S. M. Rubin. 1989. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among White postmenopausal women. Archives of Internal Medicine 149:2445-48.
4. Feuer, E. J., L. Wung, C. C. Boring, W. D. Flanders, M. J. Timmel, and T. Tong. 1993. The lifetime risk of developing breast cancer. Journal of the National Cancer Institute 85:892-97.
5. Garfinkel, L. 1995. Probability of developing or dying of cancer: United States, 1991. Statistical Bulletin of the Metropolitan Insurance Company 76:31-7.
6. Gilson, L., R. Mkanje, H. Grosskurth, F. Mosha, J. Picard, A. Gavyole, J. Todd, P. Mayaud, R. Swai, L. Fransen, D. Mabey, A. Mills, and R. Hayes. 1997. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet 350:1805-9.
7. Gold, M. R., J. E. Siegel, L. B. Russell, and M. C. Weinstein, eds. 1996. Cost-effectiveness in health and medicine. New York: Oxford University Press.
8. Haddix, A. C., S. M. Teutsch, P. A. Shaffer, and D. O. Duñet, eds. 1996. Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press.
9. Hatziandrue, E. J., J. J. Sacks, R. Brown, W. R. Taylor, M. L. Rothenberg, and J. D. Graham. 1995. The cost-effectiveness of three programs to increase use of bicycle helmets among children. Public Health Reports 110:251-59.
10. Holtgrave, D. R., and J. A. Kelly. 1996. Preventing HIV/AIDS among high-risk urban women: The cost-effectiveness of a behavioral group intervention. American Journal of Public Health 86:1442-45.
11. _. 1997. The cost-effectiveness of an HIV prevention intervention for gay men. AIDS and Behavior 1:173-80.
12. Holtgrave, D. R., L. C. Leviton, D. A. Wagstaff, and S. D. Pinkerton. 1997. The cumulative probability of HIV infection: A summary risk measure for HIV prevention intervention studies. AIDS and Behavior 1:169-72.
13. Holtgrave, D. R., and S. D. Pinkerton. 1997. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of the Acquired Immune Deficiency Syndromes 16:54-62.
14. Howell, M. R., T. C. Quinn, W. Brathwaite, and C. A. Gaydos. 1997. Performance and cost-effectiveness of selective screening criteria for chlamydia trachomatis infection in women. Sexually Transmitted Diseases 24:131-41.
15. _. 1998. Screening women for chlamydia trachomatis in family planning clinics. Sexually Transmitted Diseases 25:108-17.
16. Kahn, J. G. 1993. Are NEPs cost-effective in preventing HIV infections? In Public health impact of needle exchange programs in the United States and abroad, edited by P. Lurie and L. Reingold. Berkeley: School of Public Health, University of California.
17. Kahn, J. G., and K. C. Haynes-Sanstad. 1997. The role of cost-effectiveness analysis in assessing HIV-prevention interventions. AIDS & Public Policy Journal 12:21-30.
18. Kaplan, E. H., and M. L. Brandeau, eds. 1994. Modeling the AIDS epidemic: Planning, policy, and prediction. New York: Raven Press.
19. King-Spooner, S. 1999. HIV prevention and the positive population. International Journal of STD & AIDS 10:141-50.
20. Lloyd-Jones, D. M., M. G. Larson, A. Beiser, and D. Levy. 1999. Lifetime risk of developing coronary heart disease. Lancet 353:89-92.
21. Lurie, P., and E. Drucker. 1997. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet 349:604-8.
22. Mansergh, G., A. C. Haddix, R. W. Steketee, P. I. Neiburg, D. J. Hu, R. J. Simonds, and M. Rogers. 1996. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 transmission infection in a sub-Saharan African developing country setting. Journal of the American Medical Association 276:139-45.
23. Mattson, M. E., E. S. Pollack, and J. W. Cullen. 1987. What are the odds that smoking will kill you? American Journal of Public Health 77:425-31.
24. Moses, S., F. A. Plummer, E. N. Ngugi, N.J.D. Nagelkerke, A. O. Anzala, and J. O. Ndinya-Achola. 1991. Controlling HIV in Africa: Effectiveness and cost of an intervention in a high-frequency STD transmitter core group. AIDS 5:407-11.
25. Pinkerton, S. D., and P. R. Abramson. 1994. An alternative model of the reproductive rate of HIV infection: Formulation, evaluation, and implications for risk reduction interventions. Evaluation Review 18:371-88.
26. _. 1998. The Bernoulli-process model of HIV transmission: Applications and implications. In Handbook of economic evaluation of HIV prevention programs, edited by D. R. Holtgrave. New York: Plenum.
27. Pinkerton, S. D., P. R. Abramson, S. C. Kalichman, S. L. Katz, and A. P. Johnson-Masotti. 2000. Secondary HIV transmission rates in a mixed-gender sample. International Journal of STD & AIDS 11:38-44.
28. Pinkerton, S. D., and D. R. Holtgrave. 1998a. Assessing the cost-effectiveness of HIV prevention interventions: A primer. In Handbook of economic evaluation of HIVprevention programs, edited by D. R. Holtgrave. New York: Plenum.
29. _. 1998b. A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS and Behavior 2:189-201.
30. Pinkerton, S. D., D. R. Holtgrave, and F. R. Bloom. 1998. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS 12:1067-78.
31. Pinkerton, S. D., D. R. Holtgrave, W. J. DiFranceisco, L. Y. Stevenson, and J. A. Kelly. 1998. Cost-effectiveness of a community-level HIV risk reduction intervention. American Journal of Public Health 88:1239-42.
32. Pinkerton, S. D., D. R. Holtgrave, L. C. Leviton, D. A. Wagstaff, and P. R. Abramson. 1998. Model-based evaluation of HIV prevention interventions. Evaluation Review 22:155-74.
33. Pinkerton, S. D., D. R. Holtgrave, L. C. Leviton, D. A. Wagstaff, H. Cecil, and P. R. Abramson. 1998. Toward a standard sexual behavior data set for HIV prevention evaluation. American Journal of Health Behavior 22:259-66.
34. Pinkerton, S. D., D. R. Holtgrave, and R. O. Valdiserri. 1997. Cost-effectiveness of HIV prevention skills training for men who have sex with men. AIDS 11:347-57.
35. Rehle, T. M., T. J. Saidel, S. E. Hassig, P. D. Bouey, E. M. Gaillard, and D. C. Sokal. 1998. AVERT: A user-friendly model to estimate the impact of HIV/sexually transmitted disease prevention programs on HIV transmission. AIDS 12 (suppl. 2): S27-S35.
36. Russell, L. B. 1986. Is prevention better than cure? Washington, DC: Brookings Institution.
37. Schwager, S. J., C. Castillo-Chavez, and H. Hethcoate. 1989. Statistical and mathematical approaches in HIV/AIDS modeling: A review. In Mathematical and statistical approaches to AIDS epidemiology, edited by C. Castillo-Chavez. Berlin: Springer-Verlag.
38. Siegel, J. E., M. C. Weinstein, and H. V. Fineberg. 1991. Bleach programs for preventing AIDS among IV drug users: Modeling the impact of HIV prevalence. American Journal of Public Health 81:1273-79.
39. St. Lawrence, J. S., T. L. Brasfield, Y. E. Diaz, K. W. Jefferson, M. T. Reynolds, and M. O. Leonard. 1994. Three-year follow-up of an HIV risk-reduction intervention that used popular peers. American Journal of Public Health 84:2027-28.
40. Weinstein, M. C., J. D. Graham, J. E. Siegel, and H. V. Fineberg. 1989. Cost-effectiveness analysis of AIDS prevention programs: Concepts, complications, and illustrations. In AIDS: Sexual behavior and intravenous drug use, edited by C. F. Turner, H. G. Miller, and L. E. Moses. Washington, DC: National Academy Press.